BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30725006)

  • 1. [Evaluation of the lateral flow Aspergillus assay for the diagnosis of invasive aspergillosis, experience in a university hospital].
    Delama I; Legarraga P; González T; García P; Rabagliati R
    Rev Chilena Infectol; 2018; 35(5):574-579. PubMed ID: 30725006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
    Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
    Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
    J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
    Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
    Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Aspergillus galactomannan lateral flow assay for the diagnosis of invasive aspergillosis: A single-centre study.
    Serin I; Dogu MH
    Mycoses; 2021 Jun; 64(6):678-683. PubMed ID: 33683715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
    Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
    Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the diagnosis of invasive aspergillosis by the detection of Aspergillus in broncho-alveolar lavage fluid: Comparison of non-culture-based assays.
    Guegan H; Robert-Gangneux F; Camus C; Belaz S; Marchand T; Baldeyrou M; Gangneux JP
    J Infect; 2018 Feb; 76(2):196-205. PubMed ID: 29248586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of two lateral flow assays in BAL fluids for the detection of invasive pulmonary aspergillosis: A retrospective two-centre study.
    Scharmann U; Verhasselt HL; Kirchhoff L; Buer J; Rath PM; Steinmann J; Ziegler K
    Mycoses; 2020 Dec; 63(12):1362-1367. PubMed ID: 32885514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.
    Mikulska M; Furfaro E; De Carolis E; Drago E; Pulzato I; Borghesi ML; Zappulo E; Raiola AM; Grazia CD; Del Bono V; Cittadini G; Angelucci E; Sanguinetti M; Viscoli C
    Med Mycol; 2019 Nov; 57(8):987-996. PubMed ID: 30753590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
    Musher B; Fredricks D; Leisenring W; Balajee SA; Smith C; Marr KA
    J Clin Microbiol; 2004 Dec; 42(12):5517-22. PubMed ID: 15583275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the Aspergillus galactomannan lateral flow assay with a digital reader for the diagnosis of invasive aspergillosis: a multicenter study.
    Guo J; Xiao C; Tian W; Lv L; Hu L; Ni L; Wang D; Li W; Qiao D; Wu W
    Eur J Clin Microbiol Infect Dis; 2024 Feb; 43(2):249-257. PubMed ID: 38030860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.
    Prattes J; Flick H; Prüller F; Koidl C; Raggam RB; Palfner M; Eigl S; Buzina W; Zollner-Schwetz I; Thornton CR; Krause R; Hoenigl M
    Am J Respir Crit Care Med; 2014 Oct; 190(8):922-9. PubMed ID: 25203869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Efficacy of Aspergillus Galactomannan Lateral Flow Assay in Patients with Hematological Malignancies: A Prospective Multicenter Study.
    Alhan O; Saba R; Akalin EH; Ener B; Ture Yuce Z; Deveci B; Guncu MM; Kahveci HN; Yilmaz AF; Odabasi Z
    Mycopathologia; 2023 Oct; 188(5):643-653. PubMed ID: 37273172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus-specific Lateral Flow Device test in bronchoalveolar lavage.
    Jenks JD; Mehta SR; Taplitz R; Aslam S; Reed SL; Hoenigl M
    Mycoses; 2019 Mar; 62(3):230-236. PubMed ID: 30565352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
    Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
    J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples.
    Danylo A; Courtemanche C; Pelletier R; Boudreault AA
    Med Mycol; 2014 Aug; 52(6):577-83. PubMed ID: 25023484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Park SY; Lee SO; Choi SH; Sung H; Kim MN; Choi CM; Hong SB; Oh YM; Shim TS; Koh Y; Kim YS; Woo JH; Kim SH
    J Infect; 2010 Dec; 61(6):492-8. PubMed ID: 20833201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test.
    Eigl S; Prattes J; Reinwald M; Thornton CR; Reischies F; Spiess B; Neumeister P; Zollner-Schwetz I; Raggam RB; Flick H; Buchheidt D; Krause R; Hoenigl M
    Int J Antimicrob Agents; 2015 Oct; 46(4):401-5. PubMed ID: 26187363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.